Submitted by Anonymous (not verified) on 30 April 2024 - 10:51
Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 6, Status: Authorised
Source: